CYANOCOBALAMIN Drug Patent Profile
When do Cyanocobalamin patents expire, and what generic alternatives are available?
Cyanocobalamin is a drug marketed by Abraxis Pharm, Am Regent, Aspiro, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland, H2-pharma, Luitpold, Lyphomed, Mankind Pharma, Meitheal, Mylan Institutional, Pharmobedient, Sagent Pharms Inc, Sandoz, Sanofi Aventis Us, Sola Pharms, Solopak, Somerset Theraps Llc, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Xiromed, Zydus Pharms, Lupin, Padagis Israel, and West Ward. and is included in thirty-two NDAs.
The generic ingredient in CYANOCOBALAMIN is cyanocobalamin. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cyanocobalamin
A generic version of CYANOCOBALAMIN was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYANOCOBALAMIN?
- What are the global sales for CYANOCOBALAMIN?
- What is Average Wholesale Price for CYANOCOBALAMIN?
Summary for CYANOCOBALAMIN
Recent Clinical Trials for CYANOCOBALAMIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Laboratorios Silanes S.A. de C.V. | PHASE3 |
| Fundação Educacional Serra dos Órgãos | Phase 4 |
| University of Kansas Medical Center | Phase 2 |
Pharmacology for CYANOCOBALAMIN
| Drug Class | Vitamin B12 |
Anatomical Therapeutic Chemical (ATC) Classes for CYANOCOBALAMIN
Paragraph IV (Patent) Challenges for CYANOCOBALAMIN
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| NASCOBAL | Nasal Spray | cyanocobalamin | 500 mcg/spray | 021642 | 1 | 2017-04-28 |
US Patents and Regulatory Information for CYANOCOBALAMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West-ward Pharms Int | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 080515-002 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Somerset Theraps Llc | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 209429-001 | Dec 18, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Wyeth Ayerst | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 080554-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
